Abstract:Doxorubicin (DOX) has a cytotoxic effect on many tumor cells; however, its clinical application is limited owing to its strong side effects. Although Doxil® reduces the cardiotoxicity of free DOX, it has also introduced a new dose-limiting toxicity. In a previous study, a sialic acid-cholesterol conjugate (SA-CH) was synthesized and modified onto the surface of DOX-loaded liposomes to target tumor-associated macrophages (TAMs), further improving the efficacy of DOX-loaded liposomes over that of Doxil®. Meanwhile, the good retention characteristics and promising antitumor ability of sphingomyelin/cholesterol (SM/CH) system for water-soluble drugs have attracted wide attention. Therefore, we aimed to use SA-CH as the target and hydrogenated soybean phosphatidylcholine (HSPC) or egg sphingomyelin (ESM) as the membrane material to develop a more stable DOX-loaded liposome with stronger antitumor activity. The liposomes were evaluated for particle size, polydispersity index, zeta potential, entrapment efficiency, in vitro release, long-term storage, cytotoxicity, cellular uptake, pharmacokinetics, tumor targetability, and in vivo antitumor activity. In the liposomes prepared using HSPC/CH, sialic acid (SA) modification considerably increased the accumulation of DOX-loaded liposomes in the tumor, thus exerting a better antitumor effect. However, SA modification in DOX-ESL (SA-CH-modified DOX-loaded liposomes prepared by ESM/CH) destroyed the strong retention effect of the ESM/CH system on DOX, resulting in a reduced antitumor effect. Notably, DOX-ECL (DOX-loaded liposome prepared by ESM/CH) had the optimal storage stability, lowest toxicity, and optimal antitumor effect due to better drug retention properties. Thus, the ESM/CH liposome of DOX is a potential drug delivery system. Graphical Sketch of the effect of two DOX-loaded liposomes with hydrogenated soybean phospholipid (HSPC) and egg sphingomyelin (ESM) as lipid membrane material and surface-modified SA derivative on tumor growth inhibition.

Development of oral delivery systems with enhanced antioxidant and anticancer activity: Coix seed oil and β-carotene co-loaded liposomes.

Preparation of Coix Seed Oil Bioactive Delivery Systems Based on Homologous Polysaccharides and Proteins.

Synthesis and Characterization of Fucoidan/chitosan-Coated Nanoliposomes for Enhanced Stability and Oral Bioavailability of Hydrophilic Catechin and Hydrophobic Juglone

Synthesis, Characterization of Liposomes Modified with Biosurfactant MEL-A Loading Betulinic Acid and Its Anticancer Effect in HepG2 Cell

Increases of Lipophilic Antioxidants and Anticancer Activity of Coix Seed Fermented by Monascus purpureus

Physicochemical properties, antioxidant activities and in vitro sustained release behaviour of co-encapsulated liposomes as vehicle for vitamin E and β-carotene

Co-loading and Intestine-Specific Delivery of Multiple Antioxidants in Ph-Responsive Microspheres Based on TEMPO-oxidized Polysaccharides.

Co-Encapsulation of EGCG and Quercetin in Liposomes for Optimum Antioxidant Activity.

Preparation and Characterization of Antarctic Krill Oil/quercetin Co-Loaded Liposomes and Their Protective Effect on Oleic Acid-Induced Steatosis and Oxidative Stress in Vitro.

Proliposomes for Oral Delivery of Total Biflavonoids Extract from Selaginella Doederleinii: Formulation Development, Optimization, and in Vitro-in Vivo Characterization.

A Novel Delivery System for the Combined Use of Natural Ingredients: The Preparation of Berberine Hydrochloride–Matrine Liposomes and Preliminary Exploration of Their Anti-Tumor Activity

Biocompatible and Biodegradable Nanoparticles for Enhancement of Anti-Cancer Activities of Phytochemicals

Liposomes delivery systems of functional substances for precision nutrition

Co-encapsulation of Vitamin C and Β-Carotene in Liposomes: Storage Stability, Antioxidant Activity, and in Vitro Gastrointestinal Digestion.

Enhancing Solubility and Bioavailability of Octacosanol: Development of a Green O/W Nanoemulsion Synthesis Process

Preparation and evaluation of a chitosan-coated antioxidant liposome containing vitamin C and folic acid.

Improved Oral Bioavailability and Target Delivery of 6-Shogaol Via Vitamin E TPGS-modified Liposomes: Preparation, In-Vitro and In-Vivo Characterizations

Liposomal Doxorubicin: the Sphingomyelin/Cholesterol System Significantly Enhances the Antitumor Efficacy of Doxorubicin

A Novel Formulation of [6]-Gingerol: Proliposomes with Enhanced Oral Bioavailability and Antitumor Effect.

Advancing Liposomal Coating Approaches for Improved Anticancer Drug Delivery

Preparation and evaluation of vitamin C and folic acid-coloaded antioxidant liposomes